376 related articles for article (PubMed ID: 25046137)
1. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
[TBL] [Abstract][Full Text] [Related]
2. L-Carnitine supplementation decreases DNA damage in treated MSUD patients.
Mescka CP; Guerreiro G; Hammerschmidt T; Faverzani J; de Moura Coelho D; Mandredini V; Wayhs CA; Wajner M; Dutra-Filho CS; Vargas CR
Mutat Res; 2015 May; 775():43-7. PubMed ID: 25867118
[TBL] [Abstract][Full Text] [Related]
3. L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.
Mescka CP; Rosa AP; Schirmbeck G; da Rosa TH; Catarino F; de Souza LO; Guerreiro G; Sitta A; Vargas CR; Dutra-Filho CS
Mol Neurobiol; 2016 Nov; 53(9):6007-6017. PubMed ID: 26526843
[TBL] [Abstract][Full Text] [Related]
4. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
[TBL] [Abstract][Full Text] [Related]
5. In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease.
Mescka C; Moraes T; Rosa A; Mazzola P; Piccoli B; Jacques C; Dalazen G; Coelho J; Cortes M; Terra M; Regla Vargas C; Dutra-Filho CS
Metab Brain Dis; 2011 Mar; 26(1):21-8. PubMed ID: 21380499
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
Amaral AU; Wajner M
Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
[TBL] [Abstract][Full Text] [Related]
7. Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation.
Mescka CP; Guerreiro G; Donida B; Marchetti D; Wayhs CA; Ribas GS; Coitinho AS; Wajner M; Dutra-Filho CS; Vargas CR
Metab Brain Dis; 2015 Oct; 30(5):1167-74. PubMed ID: 26002427
[TBL] [Abstract][Full Text] [Related]
8. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
[TBL] [Abstract][Full Text] [Related]
9. Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect.
Mescka CP; Wayhs CA; Vanzin CS; Biancini GB; Guerreiro G; Manfredini V; Souza C; Wajner M; Dutra-Filho CS; Vargas CR
Int J Dev Neurosci; 2013 Feb; 31(1):21-4. PubMed ID: 23137711
[TBL] [Abstract][Full Text] [Related]
10. DNA damage induced by alloisoleucine and other metabolites in maple syrup urine disease and protective effect of l-carnitine.
Hauschild TC; Guerreiro G; Mescka CP; Coelho DM; Steffens L; Moura DJ; Manfredini V; Vargas CR
Toxicol In Vitro; 2019 Jun; 57():194-202. PubMed ID: 30853490
[TBL] [Abstract][Full Text] [Related]
11. Urinary biomarkers of oxidative damage in Maple syrup urine disease: the L-carnitine role.
Guerreiro G; Mescka CP; Sitta A; Donida B; Marchetti D; Hammerschmidt T; Faverzani J; Coelho Dde M; Wajner M; Dutra-Filho CS; Vargas CR
Int J Dev Neurosci; 2015 May; 42():10-4. PubMed ID: 25680940
[TBL] [Abstract][Full Text] [Related]
12. DNA damage in an animal model of maple syrup urine disease.
Scaini G; Jeremias IC; Morais MO; Borges GD; Munhoz BP; Leffa DD; Andrade VM; Schuck PF; Ferreira GC; Streck EL
Mol Genet Metab; 2012 Jun; 106(2):169-74. PubMed ID: 22560665
[TBL] [Abstract][Full Text] [Related]
13. alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats.
Bridi R; Braun CA; Zorzi GK; Wannmacher CM; Wajner M; Lissi EG; Dutra-Filho CS
Metab Brain Dis; 2005 Jun; 20(2):155-67. PubMed ID: 15938133
[TBL] [Abstract][Full Text] [Related]
14. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease.
Barschak AG; Sitta A; Deon M; de Oliveira MH; Haeser A; Dutra-Filho CS; Wajner M; Vargas CR
Metab Brain Dis; 2006 Dec; 21(4):279-86. PubMed ID: 17091400
[TBL] [Abstract][Full Text] [Related]
15. Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain.
Amaral AU; Leipnitz G; Fernandes CG; Seminotti B; Schuck PF; Wajner M
Brain Res; 2010 Apr; 1324():75-84. PubMed ID: 20153737
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease.
Sgaravatti AM; Rosa RB; Schuck PF; Ribeiro CA; Wannmacher CM; Wyse AT; Dutra-Filho CS; Wajner M
Biochim Biophys Acta; 2003 Nov; 1639(3):232-8. PubMed ID: 14636955
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the branched-chain alpha-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral cortex.
Funchal C; Gottfried C; De Almeida LM; Wajner M; Pessoa-Pureur R
Glia; 2004 Nov; 48(3):230-40. PubMed ID: 15390119
[TBL] [Abstract][Full Text] [Related]
18. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease.
Bridi R; Araldi J; Sgarbi MB; Testa CG; Durigon K; Wajner M; Dutra-Filho CS
Int J Dev Neurosci; 2003 Oct; 21(6):327-32. PubMed ID: 12927581
[TBL] [Abstract][Full Text] [Related]
19. Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts.
Wendel U; Wentrup H; Rüdiger HW
Pediatr Res; 1975 Sep; 9(9):709-17. PubMed ID: 1202420
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
